APO Apollo posts 193 percent Q4 2025 EPS beat even as shares dip 104 percent in todays trading BEP Brook Renew posts wider than expected Q1 2026 per share loss even as its stock rises modestly What makes SBC SBC a compelling holding for the long term Momentum Fading 20260508 EIKN Eikon Therapeutics CEO outlines strategic pipeline expansion priorities ahead of key clinical trial milestones